Ivan Kmezic
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Rituximab in New-Onset Generalized Myasthenia Gravis: Long-Term Follow-Up of the RINOMAX Clinical Trial.
Journal: European journal of neurology
Published: July 08, 2025
Beta-trace protein in chronic inflammatory demyelinating polyradiculoneuropathy and Guillain-Barré syndrome - clinical utilization and a new insight into pathophysiological mechanisms.
Journal: Journal of the neurological sciences
Published: October 29, 2024
Low-dose rituximab treatment in a patient with anti-neurofascin-155 IgG4 autoimmune nodopathy.
Journal: Journal of neuroimmunology
Published: December 28, 2023
Neurodegenerative biomarkers outperform neuroinflammatory biomarkers in amyotrophic lateral sclerosis.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: October 04, 2023
Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay.
Journal: Frontiers in immunology
Published: June 16, 2023
Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies.
Journal: European journal of neurology
Published: March 16, 2022
Measurement of sCD27 in the cerebrospinal fluid identifies patients with neuroinflammatory disease.
Journal: Journal of neuroimmunology
Published: January 21, 2019
An unusual cause of fatal rapid-onset ataxia plus syndrome.
Journal: Cerebellum & ataxias
Published: November 06, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026